Canadian researchers discover brain inflammation in people with OCDFinding could lead to development of new treatments for the condition Comorbid disorders may affect methadone maintenance treatmentComorbid cocaine or tranquilizer use disorder may increase rates of continuing opioid use Be aware of antidepressant discontinuation syndrome Key points to help with detection, prevention and management Cape Breton pharmacist to share battle with depression on TV National segment set to air May 10 Rexulti: new atypical antipsychotic for schizophrenia Serotonin-dopamine activity modulator improves symptoms of schizophrenia No link between prenatal antidepressants and autism: two studies Canadian and Swedish data back safety of the drugs in pregnancy BC genome project moves to phase two Focus will be on drugs for mental health conditions. Inappropriate drugs common in nursing home residents with dementia Ontario study shows medications of ‘questionable benefit’ common in last week of life Evidence for off-label antidepressants often lacking Only three indications backed by strong science, Quebec study shows Majority of melatonin supplements do not meet labelled claims for melatonin content Melatonin content varies widely and 26% of products contain serotonin as a contaminant. First Previous 43 44 45 46 47 Next Last
